LLY CEO David Ricks Buys 1,632 Shares at $644.77 - Form 4

Q: What did the Form 4 filed for LLY report about David A. Ricks' transaction?

The Form 4 reports a purchase of 1,632 shares of Eli Lilly common stock on 08/12/2025 at a weighted average price of $644.769 per share.

Q: How many Eli Lilly shares does David A. Ricks report beneficially owning after the transaction?

The filing shows 546,601.167 shares beneficially owned following the reported transaction.

Q: What indirect holdings does the Form 4 list for David A. Ricks (LLY)?

Indirect holdings disclosed include 54,117 shares in a 2022 GRAT, 300 shares by a Trust, 68,656 shares in a SLAT, and 7,295.84 shares in a 401(k).

Q: What price range and weighted average price were disclosed for the purchase on the LLY Form 4?

Individual purchases were made between $644.45 and $645.11 , and the weighted average price is reported as $644.769 .

Q: Did the filing disclose any transfers to David A. Ricks prior to the reported purchase?

Yes. The footnotes state that on May 15, 2025 , 5,340 shares were transferred to the reporting person as an annuity payment from the Grantor Retained Annuity Trust.

[Form 4] Eli Lilly & Co. Insider Trading Activity

Filing Impact

(High)

Filing Sentiment

(Positive)

Form Type

Rhea-AI Filing Summary

David A. Ricks, President, Chair and CEO of Eli Lilly & Co., reported an open-market purchase of common stock. The Form 4 shows a purchase of 1,632 shares on 08/12/2025 at a weighted average price of $644.769 per share, with individual trade prices in the range $644.45 to $645.11. Following the reported transaction the filing shows 546,601.167 shares beneficially owned by the reporting person.

The filing also discloses indirect holdings: 54,117 shares in a 2022 GRAT, 300 shares by a Trust, 68,656 shares by a SLAT, and 7,295.84 shares in a 401(k). Footnotes state 16 shares from a family member's retirement account are included and that 5,340 shares were transferred to the reporting person on May 15, 2025 as an annuity payment under the GRAT.

Positive

CEO purchase disclosed: David A. Ricks purchased 1,632 shares, showing an insider acquisition
Clear pricing disclosure: weighted average purchase price provided as $644.769 with an explicit price range
Detailed ownership breakdown: filing lists direct and multiple indirect holdings (GRAT, SLAT, Trust, 401(k)) and an annuity transfer of 5,340 shares

Negative

None.

Insights

TL;DR: CEO David Ricks purchased 1,632 LLY shares at a weighted average of $644.769, increasing direct reported holdings to 546,601.167 shares.

The filing documents a modest open-market purchase by the company's CEO at a weighted average price of $644.769, with executed prices between $644.45 and $645.11. The disclosure quantifies both direct and detailed indirect holdings, including a 2022 GRAT and other trusts, and notes a prior annuity transfer of 5,340 shares. For investors, the filing provides clear, itemized ownership information; the purchase itself is relatively small relative to total reported beneficial ownership but is a direct acquisition by a senior executive.

TL;DR: Form 4 includes required disclosures, footnotes, and disclaimers showing detailed direct and indirect ownership reporting by the CEO.

The submission includes explicit footnotes explaining the weighted average price, inclusion of family retirement-account shares, an annuity transfer from the GRAT, and a standard disclaimer regarding pecuniary interest. The filing is signed by an authorized representative, indicating procedural compliance with Section 16 reporting. The disclosure of multiple indirect vehicles (GRAT, SLAT, Trust, 401(k)) provides transparency about how control and economic interests are allocated.

08/12/2025 - 04:23 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Ricks David A

(Last)

(First)

(Middle)

LILLY CORPORATE CENTER

(Street)

INDIANAPOLIS

46285

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
ELI LILLY & Co [ LLY ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	President, Chair, and CEO

3. Date of Earliest Transaction (Month/Day/Year)
08/12/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	08/12/2025		P		1,632	A	$644.769⁽¹⁾	546,601.167⁽²⁾	D⁽³⁾
Common Stock								54,117	I⁽³⁾	By David A. Ricks 2022 GRAT
Common Stock								300	I⁽⁴⁾	By Trust
Common Stock								68,656	I⁽⁴⁾	By David A. Ricks SLAT
Common Stock								7,295.84	I	401(k)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $644.45 to $645.11, inclusive. The reporting person undertakes to provide to Eli Lilly and Company, any security holder of Eli Lilly and Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

2. Includes 16 shares previously held in a family member's retirement account.

3. On May 15, 2025, 5,340 shares of Eli Lilly and Company common stock were transferred to the reporting person as an annuity payment in accordance with the terms of the Grantor Retained Annuity Trust, of which the reporting person is the trustee.

4. The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.

Remarks:

	/s/ Jonathan Groff for David A. Ricks, pursuant to authorization on file	08/12/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source:

FAQ

What did the Form 4 filed for LLY report about David A. Ricks' transaction?

The Form 4 reports a purchase of 1,632 shares of Eli Lilly common stock on 08/12/2025 at a weighted average price of $644.769 per share.

How many Eli Lilly shares does David A. Ricks report beneficially owning after the transaction?

The filing shows 546,601.167 shares beneficially owned following the reported transaction.

What indirect holdings does the Form 4 list for David A. Ricks (LLY)?

Indirect holdings disclosed include 54,117 shares in a 2022 GRAT, 300 shares by a Trust, 68,656 shares in a SLAT, and 7,295.84 shares in a 401(k).

What price range and weighted average price were disclosed for the purchase on the LLY Form 4?

Individual purchases were made between $644.45 and $645.11, and the weighted average price is reported as $644.769.

Did the filing disclose any transfers to David A. Ricks prior to the reported purchase?

Yes. The footnotes state that on May 15, 2025, 5,340 shares were transferred to the reporting person as an annuity payment from the Grantor Retained Annuity Trust.

AG真人官方

[Form 4] Eli Lilly & Co. Insider Trading Activity

Insights

FAQ

What did the Form 4 filed for LLY report about David A. Ricks' transaction?

How many Eli Lilly shares does David A. Ricks report beneficially owning after the transaction?

What indirect holdings does the Form 4 list for David A. Ricks (LLY)?

What price range and weighted average price were disclosed for the purchase on the LLY Form 4?

Did the filing disclose any transfers to David A. Ricks prior to the reported purchase?

NYSE:LLY

LLY Rankings

LLY Latest News

LLY Latest SEC Filings

LLY Stock Data

AG真人官方

Trending News

[Form 4] Eli Lilly & Co. Insider Trading Activity

Insights

Securities Analyst positive

Corporate Governance Expert neutral

FAQ

What did the Form 4 filed for LLY report about David A. Ricks' transaction?

How many Eli Lilly shares does David A. Ricks report beneficially owning after the transaction?

What indirect holdings does the Form 4 list for David A. Ricks (LLY)?

What price range and weighted average price were disclosed for the purchase on the LLY Form 4?

Did the filing disclose any transfers to David A. Ricks prior to the reported purchase?

NYSE:LLY

LLY Rankings

LLY Latest News

LLY Latest SEC Filings

LLY Stock Data